In Vivo Expansion of Cancer Stemness Affords Novel Cancer Stem Cell Targets: Malignant Rhabdoid Tumor as an Example

Ailles, 2007, Cancer stem cells in solid tumors, Curr. Opin. Biotechnol., 18, 460, 10.1016/j.copbio.2007.10.007 Ball, 2017, Succession of transiently active tumor-initiating cell clones in human pancreatic cancer xenografts, EMBO Mol. Med., 9, 918, 10.15252/emmm.201607354 Barker, 2012, The rationale for targeting the LOX family in cancer, Nat. Rev., 12, 540, 10.1038/nrc3319 Batlle, 2017, Cancer stem cells revisited, Nat. Med., 23, 1124, 10.1038/nm.4409 Bertucci, 2013, Gene expression profiling of solitary fibrous tumors, PLoS One, 8, e64497, 10.1371/journal.pone.0064497 Bondareva, 2009, The lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cells, PLoS One, 4, e5620, 10.1371/journal.pone.0005620 Boufraqech, 2016, Lysyl oxidase (LOX) transcriptionally regulates SNAI2 expression and TIMP4 secretion in human cancers, Clin. Cancer Res., 22, 4491, 10.1158/1078-0432.CCR-15-2461 Cox, 2015, The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase, Nature, 522, 106, 10.1038/nature14492 De Donato, 2017, Uncovering the role of nuclear lysyl oxidase (LOX) in advanced high grade serous ovarian cancer, Gynecol. Oncol., 146, 170, 10.1016/j.ygyno.2017.05.001 Deisch, 2011, Immunohistochemical expression of embryonic stem cell markers in malignant rhabdoid tumors, Pediatr. Dev. Pathol., 14, 353, 10.2350/10-09-0902-OA.1 Dekel, 2006, Multiple imprinted and stemness genes provide a link between normal and tumor progenitor cells of the developing human kidney, Cancer Res., 66, 6040, 10.1158/0008-5472.CAN-05-4528 Edwards, 2016, Hypermutation of DPYD deregulates pyrimidine metabolism and promotes malignant progression, Mol. Cancer Res., 14, 196, 10.1158/1541-7786.MCR-15-0403 Fouani, 2017, Metals and metastasis: exploiting the role of metals in cancer metastasis to develop novel anti-metastatic agents, Pharmacol. Res., 115, 275, 10.1016/j.phrs.2016.12.001 Garvin, 1993, The G401 cell line, utilized for studies of chromosomal changes in Wilms' tumor, is derived from a rhabdoid tumor of the kidney, Am. J. Pathol., 142, 375 Ginestier, 2007, ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome, Cell Stem Cell, 1, 555, 10.1016/j.stem.2007.08.014 Hu, 2009, ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays, J. Immunol. Methods, 347, 70, 10.1016/j.jim.2009.06.008 Iturbide, 2015, A new role for LOX and LOXL2 proteins in transcription regulation, FEBS J., 282, 1768, 10.1111/febs.12961 Kordes, 2003, Clinical and molecular features in patients with atypical teratoid rhabdoid tumor or malignant rhabdoid tumor, Genes Chromosomes Cancer, 49, 176, 10.1002/gcc.20729 Laidlaw, 2016, Cooperation of imipramine blue and tyrosine kinase blockade demonstrates activity against chronic myeloid leukemia, Oncotarget, 7, 51651, 10.18632/oncotarget.10541 Liu, 2017, Nuclear expression of lysyl oxidase enzyme is an independent prognostic factor in rectal cancer patients, Oncotarget, 8, 60015, 10.18632/oncotarget.9623 Martinez-Cruzado, 2016, Aldh1 expression and activity increase during tumor evolution in sarcoma cancer stem cell populations, Sci. Rep., 6, 27878, 10.1038/srep27878 Mello, 2011, Chromatin supraorganization, mitotic abnormalities and proliferation in cells with increased or down-regulated lox expression: indirect evidence of a LOX-histone H1 interaction in vivo, Micron, 42, 8, 10.1016/j.micron.2010.09.001 Mello, 1995, Modulation of ras transformation affecting chromatin supraorganization as assessed by image analysis, Exp. Cell Res., 220, 374, 10.1006/excr.1995.1328 Melstrom, 2008, Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model, Clin. Cancer Res., 14, 6525, 10.1158/1078-0432.CCR-07-4631 Metsuyanim, 2009, Expression of stem cell markers in the human fetal kidney, PLoS One, 4, e6709, 10.1371/journal.pone.0006709 Millanes-Romero, 2013, Regulation of heterochromatin transcription by Snail1/LOXL2 during epithelial-to-mesenchymal transition, Mol. Cell, 52, 746, 10.1016/j.molcel.2013.10.015 Mizikova, 2017, Perturbations to lysyl oxidase expression broadly influence the transcriptome of lung fibroblasts, Physiol. Genomics, 49, 416, 10.1152/physiolgenomics.00026.2017 Moore, 2011, Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance, J. Oncol., 2011 Olson, 1995, Successful treatment of disseminated central nervous system malignant rhabdoid tumor, J. Pediatr. Hematol. Oncol., 17, 71, 10.1097/00043426-199502000-00013 Parham, 1994, The clinicopathologic spectrum of putative extrarenal rhabdoid tumors. An analysis of 42 cases studied with immunohistochemistry or electron microscopy, Am. J. Surg. Pathol., 18, 1010, 10.1097/00000478-199410000-00005 Petrillo, 2012, Xenografts faithfully recapitulate breast cancer-specific gene expression patterns of parent primary breast tumors, Breast Cancer Res. Treat., 135, 913, 10.1007/s10549-012-2226-y Pleniceanu, 2017, Peroxisome proliferator-activated receptor gamma (PPARgamma) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target, EMBO Mol. Med., 9, 1763, 10.15252/emmm.201708507 Pode-Shakked, 2017, Evidence of in vitro preservation of human nephrogenesis at the single-cell level, Stem Cell Rep., 9, 279, 10.1016/j.stemcr.2017.04.026 Pode-Shakked, 2009, Developmental tumourigenesis: NCAM as a putative marker for the malignant renal stem/progenitor cell population, J. Cell. Mol. Med., 13, 1792, 10.1111/j.1582-4934.2008.00607.x Pode-Shakked, 2013, The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets, EMBO Mol. Med., 5, 18, 10.1002/emmm.201201516 Shukrun, 2014, Wilms' tumor blastemal stem cells dedifferentiate to propagate the tumor bulk, Stem Cell Rep., 3, 24, 10.1016/j.stemcr.2014.05.013 Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. USA, 102, 15545, 10.1073/pnas.0506580102 Thomas, 2013, Lysyl oxidase at the crossroads of mesenchymal stem cells and epithelial-mesenchymal transition, Oncotarget, 4, 376, 10.18632/oncotarget.919 Tomita, 2016, Aldehyde dehydrogenase 1A1 in stem cells and cancer, Oncotarget, 7, 11018, 10.18632/oncotarget.6920 Versteege, 1998, Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer, Nature, 394, 203, 10.1038/28212 Vitte, 2017, Timing of Smarcb1 and Nf2 inactivation determines schwannoma versus rhabdoid tumor development, Nat. Commun., 8, 300, 10.1038/s41467-017-00346-5 Wick, 1995, Malignant rhabdoid tumors: a clinicopathologic review and conceptual discussion, Semin. Diagn. Pathol., 12, 233